Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024

LONDON, UK – Media OutReach Newswire – 5 June 2025 – Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No. 8 global ranking by both Ukraine and Bulgaria countries. This prestigious recognition underscores Takeda’s commitment to creating a workplace that embraces diversity, equity and inclusion (DE&I), fostering an empowering culture across all locations it operates. This accolade reflects Takeda’s consistent focus on employee well-being, trust-based leadership, and a people-centered approach to business.

At Takeda, we are committed to delivering an exceptional employee experience by cultivating an inclusive, purpose-driven workplace where our people can grow both personally and professionally. Being recognized as a Best Place to Work reflects our unwavering dedication to building a culture where every colleague feels valued, supported, and empowered to thrive.

Volodymyr Pedko, General Manager of Takeda Ukraine, shared:
“It gives me great pride to receive this recognition during such challenging times! It stands as a testament to the exceptional quality of work and everyone’s commitment to building and sustaining an innovative and inclusive workplace in our organization.”

Todor Kesimov, General Manager of Takeda Romania & Bulgaria, commented:
“I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms our efforts to build a culture of trust, care, and respect in every country, including Bulgaria. This recognition inspires us to continue building a better future – for our employees, for patients, and for society.”
Hashtag: #BestPlacesToWork

The issuer is solely responsible for the content of this announcement.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit .

For more information, please visit the program website: .

More Articles From Media OutReach Newswire

Vingroup and Gulf States Pursue Sustainability-Led Growth as Legacy Powerhouses Reinvent

Vietnam’s Vingroup and Gulf states are both rewriting their growth playbooks through state-led sustainability drives, forging a parallel transformation from …

EKOUAER Debuts in Monaco as Exclusive VIP Gifting Partner on Titania Yacht

MONTE CARLO, MONACO – Media OutReach Newswire – 6 June 2025 – During the 2025 Monaco Grand Prix, EKOUAER debuted …

Inviting the World to Explore Hainan, Overseas Tour Operators Hainan Tour 2025 Will Kick Off Soon

SANYA, CHINA – Media OutReach Newswire – 6 June 2025 – At this pivotal moment when Hainan steadily advances its …

K!DZ POP CON ASIA: Exhibitor Highlights at K!DZ POP CON 2025

SINGAPORE – Media OutReach Newswire – 6 June 2025 – The ultimate kids and family event of the year, K!DZ …
Share via
Copy link